Hisamitsu Pharmaceutical Co., Inc.

HTSUF · OTC
Analyze with AI
8/31/2025
5/31/2025
2/28/2025
11/30/2024
Assets
Cash & Equivalents$103,921$104,107$114,518$102,512
Short-Term Investments$8,974$14,020$14,598$14,128
Receivables$48,676$47,089$46,879$44,542
Inventory$24,890$25,129$22,391$23,701
Other Curr. Assets$8,635$7,094$5,402$11,579
Total Curr. Assets$195,096$197,439$203,788$196,462
Property Plant & Equip (Net)$59,455$58,467$59,899$57,763
Goodwill$1,218$1,256$1,294$1,331
Intangibles$4,446$4,605$4,680$4,846
Long-Term Investments$75,879$60,168$71,494$62,565
Tax Assets$0$0$0$0
Other NC Assets$2$12,999$1,913$11,839
Total NC Assets$141,000$137,495$139,280$138,344
Other Assets$0$0$0$0
Total Assets$336,096$334,934$343,068$334,806
Liabilities
Payables$16,873$9,523$14,115$10,694
Short-Term Debt$946$963$1,474$1,071
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$32,563$35,497$31,637$43,777
Total Curr. Liab.$50,382$45,983$47,226$55,542
LT Debt$1,431$1,683$2,382$1,857
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$15,663$14,338$14,055$15,115
Total NC Liab.$17,094$16,021$16,437$16,972
Other Liabilities$0$0$0$0
Cap. Leases$0$0$1,097$0
Total Liabilities$67,476$62,004$63,663$72,514
Equity
Pref Stock$0$0$0$0
Common Stock$8,473$8,473$8,473$8,473
Retained Earnings$222,804$257,144$257,881$249,769
AOCI$48,482$49,765$55,659$46,956
Other Equity-$13,824-$45,009-$45,189-$45,311
Total Equity$265,935$270,373$276,824$259,887
Supplemental Information
Minority Interest$2,685$2,557$2,581$2,405
Total Liab. & Tot. Equity$336,096$334,934$343,068$334,806
Net Debt-$101,544-$101,461-$110,662-$99,584